These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24881310)

  • 21. [Percutaneous renal denervation as a new method of treatment of resistant arterial hypertension].
    Mach-Jamińska A; Sułowicz W
    Przegl Lek; 2012; 69(11):1215-9. PubMed ID: 23646450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistant hypertension: multivariate predictors of blood pressure response to renal denervation.
    Prochnau D; Heymel S; Göbel B; Figulla HR; Surber R
    Int J Cardiol; 2013 Oct; 168(3):3130-2. PubMed ID: 23659880
    [No Abstract]   [Full Text] [Related]  

  • 23. [Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].
    Azpiri-López JR; Assad-Morell JL; Ponce de León-Martínez E; Monreal-Puente R; Dávila-Bortoni A; Vázquez-Díaz LA; Treviño-Frutos RJ; Barrera-Oranday F; Del Angel-Soto JG; Martínez JG; Arellano-Torres M
    Arch Cardiol Mex; 2015; 85(2):154-7. PubMed ID: 25700579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of resistant hypertension in a multidisciplinary unit of renal denervation: protocol and results.
    Fontenla A; García-Donaire JA; Hernández F; Segura J; Salgado R; Cerezo C; Ruilope LM; Arribas F
    Rev Esp Cardiol (Engl Ed); 2013 May; 66(5):364-70. PubMed ID: 24775818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
    Václavík J; Táborský M; Richter D
    Clin Exp Hypertens; 2013; 35(3):192-4. PubMed ID: 22891761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal denervation--hypes and hopes.
    Lewek J; Kaczmarek K; Pokushalov E; Romanov A; Cygankiewicz I; Ptaszynski P
    Cardiovasc Ther; 2015 Jun; 33(3):141-4. PubMed ID: 25786785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal denervation: results of a single-center cohort study.
    Luetkens JA; Wilhelm K; Düsing R; Woitas RP; Thomas D; Hundt F; Doerner J; Schild HH; Nähle CP
    Rofo; 2015 Jan; 187(1):36-41. PubMed ID: 25188311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Hold the catheters"--renal denervation may not be the answer to the management of resistant or hard-to-treat hypertension.
    Moser M; Handler J
    J Am Soc Hypertens; 2014 Oct; 8(10):758-9. PubMed ID: 25418498
    [No Abstract]   [Full Text] [Related]  

  • 30. [Catheter-based treatment of drug-resistant hypertension].
    De Benedetti E
    Rev Med Suisse; 2011 Nov; 7(317):2242-4. PubMed ID: 22400353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal denervation for hypertension.
    Eleid MF; Schwartz GL; Gulati R
    Curr Probl Cardiol; 2014 Feb; 39(2):35-51. PubMed ID: 24412003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.
    Borisenko O; Beige J; Lovett EG; Hoppe UC; Bjessmo S
    J Hypertens; 2014 Mar; 32(3):681-92. PubMed ID: 24378998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study.
    Vink EE; Goldschmeding R; Vink A; Weggemans C; Bleijs RL; Blankestijn PJ
    Nephrol Dial Transplant; 2014 Aug; 29(8):1608-10. PubMed ID: 24875664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal denervation rapidly restores circulating proangiogenic hematopoietic cells in patients affected by drug-resistant hypertension.
    Imbalzano E; Mandraffino G; Ceravolo R; Di Stefano R; Saitta A
    Int J Cardiol; 2014 May; 173(3):591-2. PubMed ID: 24698255
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal denervation: unde venis et quo vadis?
    Nähle CP; Düsing R; Schild H
    Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation.
    Kanai T; Krum H
    Rev Esp Cardiol (Engl Ed); 2013 Sep; 66(9):734-40. PubMed ID: 24773680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand.
    Wongpraparut N; Tresukosol D; Roubsantisuk W; Buranakitjaroen P; Chotivoraniyakul C; Pongakasira R
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S155-61. PubMed ID: 24772593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.